Loading clinical trials...
Loading clinical trials...
The Physiology of Glucagon-like-peptide-1 Receptor Expression in Patients With Endogenous Hyperinsulinism - Correlation With Histopathology
Conditions
Interventions
111In-exendin-4 imaging
Locations
1
Switzerland
University Hospital Basel, Institute of Nuclear Medicine
Basel, Canton of Basel-City, Switzerland
Start Date
November 1, 2007
Primary Completion Date
December 1, 2011
Completion Date
December 1, 2011
Last Updated
January 9, 2015
NCT03970720
NCT04786262
NCT00001276
NCT06993103
NCT06643351
NCT07217483
Lead Sponsor
University Hospital, Basel, Switzerland
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions